A new approach to prostate cancer screening

Abstract Prostate cancer screening based on prostate-specific antigen (PSA) testing has been a matter of controversy. Although for prostate was effective in reducing mortality, it resulted overdiagnosis, which translated into unnecessary treatments and numerous adverse effects. As result, recommendations from scientific societies became increasingly restrictive. In the recent years, new approaches to have proposed. These are aimed at solving controversy between widespread vs. no screening, reconsidering PSA as tool with good benefit/risk balance. this context, European Association Urology submitted proposal Commission be performed function baseline concentrations. The recently recommended implementation organized programs men aged ≤70 years values combination follow-up magnetic resonance imaging.